We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Gliomas Rapidly Diagnosed from Serum Samples

By HospiMedica International staff writers
Posted on 10 Dec 2013
Current methods can diagnose brain cancer within two to three days, but a new technique has been created in which the disease could be diagnosed in just half an hour.

A rapid diagnostic method based upon serum samples would allow for a relatively noninvasive test and open up the possibility of screening for brain cancer using a Bioplex immunoassay.

Scientists at the University of Central Lancashire (Preston, UK) collected blood samples from 50 patients with clinically confirmed glioblastoma (GBM) brain tumors and 25 normal patients. More...
The average age of the entire sample set is 60.2 years. The Bioplex suspension array system was used to quantitate the cytokine and angiogenesis factor secretion. The technology incorporates 100 color-coded bead sets each of which is conjugated to a specific reactant. Identification is based around a laminar flow system of flow cytometry that identifies and quantitates each specific reaction based on bead color and fluorescence.

Immunohistochemical staining of formalin-fixed, paraffin embedded tissue sections of the patients used for the serum analysis was performed using antibodies raised against Follistatin-288 (AbD Serotec, Kidlington, UK). The secondary antibody, blocking reagents, avidin-biotin complex, and chromagen were in the Universal Vectastain kit (Vector Labs; Burlingame, CA, USA). The Fourier transform infrared FTIR-410 Specac ATR single reflection diamond Golden Gate spectrometer (Jasco; Easton, MD, USA) was used in absorption mode to collect spectra from all serum samples.

When the investigators transmitted infrared light directly at the serum, the light had the ability to detect its molecular vibration, meaning they could determine whether the gliomas were cancerous or not. This test can achieve a diagnosis within 30 minutes. The analytes that show a statistical difference between control serum and GBM are angiopoietin, follistatin, human growth factor, interleukin-8, leptin, platelet-derived growth factor-BB (PDGF-BB) and platelet endothelial cell adhesion molecule-1 (PECAM-1).

Matthew J. Baker, the senior author said, “The result we have achieved is a milestone and has the ability to revolutionize the clinical environment by providing objective measures for diagnoses, enabling increased efficiency and economic impact upon the health services. We hope this will also help to relieve some of the emotional stress patients experience waiting for test results.” The study was originally published in the November 2013 issue of the journal Analytical and Bioanalytical Chemistry.

Related Links:

University of Central Lancashire
AbD Serotec 
Jasco 




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.